Insider transactions

EDGAR

Context Therapeutics Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–10 of 10

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-24 Filed 2026-06-26Pasternak Andy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045789 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26West Linda Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045780 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26Smith Karen L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045778 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26Walker Luke Nathaniel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045775 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26Stacey Jennifer Evans Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045784 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26Kantoff Philip W. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (45,000) — exercise price 0.576
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.
Open filing 0001628280-26-045762 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-23Chagin Karen Deborah Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (290,000) — exercise price 2.32
Acquired (A)290,0000—290,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Open filing 0001628280-26-010637 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-23Lehr Martin A. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (815,000) — exercise price 2.32
Acquired (A)815,0000—815,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Open filing 0001628280-26-010616 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-23Minai-Azary Jennifer Lynn Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (275,000) — exercise price 2.32
Acquired (A)275,0000—275,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Open filing 0001628280-26-010642 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-23Levit Alex C. Officer: Chief Legal Officer, Corp. Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (270,000) — exercise price 2.32
Acquired (A)270,0000—270,000Direct (D) No
F1
  • F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Open filing 0001628280-26-010660 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 87

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Nextech Invest Ltd. 7,419,355 SH2,228,774 dollarsUnchanged Prior quarter: 7,419,355Open filing 0001595430-26-000015 Filed 2026-11-16 Dispute this row
Deep Track Capital, LP 7,419,355 SH2,228,774 dollarsUnchanged Prior quarter: 7,419,355Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
Soleus Capital Management, L.P. 7,063,141 SH2,121,768 dollarsUnchanged Prior quarter: 7,063,141Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager6,139,266 SH1,844,235 dollarsLower by 29,984 Prior quarter: 6,169,250Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Avidity Partners Management LP 4,060,254 SH1,219,700 dollarsLower by 938,013 Prior quarter: 4,998,267Open filing 0001791827-26-000008 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,432,052 SH1,029,616 dollarsUnchanged Prior quarter: 3,432,052Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager2,931,267 SH880,553 dollarsNot in the prior quarter’s filings read Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
TCG Crossover Management, LLC 2,682,696 SH805,882 dollarsUnchanged Prior quarter: 2,682,696Open filing 0001214659-26-014306 Filed 2026-11-16 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager1,990,444 SH597 dollarsHigher by 979,540 Prior quarter: 1,010,904Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,895,469 SH569,501 dollarsHigher by 65,160 Prior quarter: 1,830,309Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager1,455,898 SH437,352 dollarsHigher by 42,470 Prior quarter: 1,413,428Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Verdad Advisers, LP 1,133,335 SH340,454 dollarsHigher by 1,099,435 Prior quarter: 33,900Open filing 0001420506-26-002833 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager995,887 SH299,164 dollarsHigher by 978,549 Prior quarter: 17,338Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager967,475 SH290,629 dollarsLower by 73,924 Prior quarter: 1,041,399Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
LUMINUS MANAGEMENT LLC 913,715 SH274,480 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128425 Filed 2026-11-16 Dispute this row
ADAR1 Capital Management, LLC 750,969 SH225,591 dollarsUnchanged Prior quarter: 750,969Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager671,074 SH201,589 dollarsHigher by 663,624 Prior quarter: 7,450Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 634,673 SH190,402 dollarsLower by 4,205 Prior quarter: 638,878Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager623,027 SH187,157 dollarsHigher by 7,451 Prior quarter: 615,576Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager524,545 SH157,364 dollarsHigher by 496,362 Prior quarter: 28,183Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
VANGUARD FIDUCIARY TRUST CO 428,125 SH128,438 dollarsLower by 5,763 Prior quarter: 433,888Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager416,207 SH125,029 dollarsHigher by 403,818 Prior quarter: 12,389Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager298,482 SH89,664 dollarsHigher by 245,773 Prior quarter: 52,709Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
BARCLAYS PLC Partly reported under another manager297,854 SH89,475 dollarsHigher by 270,350 Prior quarter: 27,504Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
CANTOR FITZGERALD, L. P. Partly reported under another manager260,000 SH78,104 dollarsNot in the prior quarter’s filings read Open filing 0000929638-26-004323 Filed 2026-11-16 Dispute this row
MYDA Advisors LLC 250,000 SH75,100 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-014141 Filed 2026-11-13 Dispute this row
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager241,312 SH72,490 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-007537 Filed 2026-11-10 Dispute this row
Pathstone Holdings, LLC 229,018 SH68,797 dollarsHigher by 14,143 Prior quarter: 214,875Open filing 0002011612-26-000005 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 227,850 SH68,446 dollarsUnchanged Prior quarter: 227,850Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Timothy G. Youngquist 2020 Irrevocable Trust 198,384 SH59,595 dollarsUnchanged Prior quarter: 198,384Open filing 0002109159-26-000008 Filed 2026-10-13 Dispute this row
Nuveen, LLC Partly reported under another manager181,116 SH54,408 dollarsHigher by 55,598 Prior quarter: 125,518Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager148,281 SH44,543 dollarsHigher by 38,919 Prior quarter: 109,362Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
NEW YORK STATE COMMON RETIREMENT FUND 135,300 SH40,644 dollarsUnchanged Prior quarter: 135,300Open filing 0000810265-26-000008 Filed 2026-11-17 Dispute this row
HighTower Advisors, LLC 125,965 SH37,840 dollarsHigher by 113 Prior quarter: 125,852Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
Private Advisor Group, LLC 125,852 SH37,806 dollarsUnchanged Prior quarter: 125,852Open filing 0001567755-26-000005 Filed 2026-11-10 Dispute this row
XTX Topco Ltd Partly reported under another manager110,901 SH33,315 dollarsLower by 183,400 Prior quarter: 294,301Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
Clear Harbor Asset Management, LLC 92,804 SH27,878 dollarsUnchanged Prior quarter: 92,804Open filing 0001172661-26-004861 Filed 2026-11-05 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager91,766 SH27,530 dollarsHigher by 38,364 Prior quarter: 53,402Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager79,422 SH23,827 dollarsLower by 11,460 Prior quarter: 90,882Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager77,538 SH24 dollarsUnchanged Prior quarter: 77,538Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
NATIXIS 73,974 SH22,592 dollarsLower by 23,135 Prior quarter: 97,109Open filing 0001104659-26-123632 Filed 2026-11-06 Dispute this row
RHUMBLINE ADVISERS 65,229 SH19,566 dollarsLower by 4,615 Prior quarter: 69,844Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Invesco Ltd. Partly reported under another manager62,078 SH18,648 dollarsHigher by 11,461 Prior quarter: 50,617Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager59,000 SH17,700 dollarsUnchanged Prior quarter: 59,000Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Cerity Partners LLC 55,152 SH16,568 dollarsHigher by 15,152 Prior quarter: 40,000Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Partly reported under another manager45,193 SH13,576 dollarsHigher by 2,295 Prior quarter: 42,898Open filing 0000905148-26-004850 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager44,331 SH13,317 dollarsHigher by 10,210 Prior quarter: 34,121Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager44,159 SH13,265 dollarsHigher by 29,926 Prior quarter: 14,233Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager44,128 SH14,077 dollarsHigher by 5,507 Prior quarter: 38,621Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
IEQ CAPITAL, LLC 41,418 SH12,442 dollarsNot in the prior quarter’s filings read Open filing 0001779789-26-000005 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • FRANKLIN RESOURCES INC 3,803,338 SH
  • Octagon Capital Advisors LP 3,050,000 SH
  • Blue Owl Capital Holdings LP 2,934,015 SH
  • MPM BIOIMPACT LLC 1,299,046 SH
  • JANE STREET GROUP, LLC 645,209 SH
  • Qube Research Technologies Ltd 257,068 SH
  • Sixth Street Partners Management Company, L.P. 227,850 SH
  • Graham Capital Management, L.P. 163,527 SH
  • GSA CAPITAL PARTNERS LLP 159,804 SH
  • MILLENNIUM MANAGEMENT LLC 147,287 SH
  • Woodline Partners LP 77,933 SH
  • TWO SIGMA SECURITIES, LLC 61,444 SH
  • Velan Capital Investment Management LP 59,700 SH
  • TWO SIGMA INVESTMENTS, LP 25,941 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,722 SH
  • SG Americas Securities, LLC 15,462 SH
  • STATE OF WISCONSIN INVESTMENT BOARD 12,000 SH
  • Pale Fire Capital SE 11,796 SH
  • MCGUIRE CAPITAL ADVISORS INC 393 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
MPM BioImpact LLC Common Stock, par value $0.001 per share1.41,299,046.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001687078-26-000020 Dispute this row
Blue Owl Capital Holdings LP Common Stock, par value $0.001 per share3.192,934,015.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 3Open filing 0001140361-26-032506 Dispute this row
Octagon Capital Advisors LP Common Stock, $0.001 par value3.33,050,000.0006/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009404 Dispute this row
Octagon Investments Master Fund LP Common Stock, $0.001 par value3.33,050,000.0006/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009404 Dispute this row
Ting Jia Common Stock, $0.001 par value3.33,050,000.0006/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009404 Dispute this row
BlackRock, Inc. Common Stock6.76,169,25006/30/2026 Filed 2026-07-27SCHEDULE 13GOpen filing 0002012383-26-002242 Dispute this row
Great Point Partners, LLC Common Stock2.442,238,496.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 7Open filing 0001172661-26-002036 Dispute this row
Dr. Jeffrey R. Jay, M.D. Common Stock2.442,238,496.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 7Open filing 0001172661-26-002036 Dispute this row
Ms. Lillian Nordahl Common Stock2.442,238,496.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 7Open filing 0001172661-26-002036 Dispute this row
Octagon Capital Advisors LP Common Stock, $0.001 par value5.75,250,000.0003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001214659-26-006201 Dispute this row
Octagon Investments Master Fund LP Common Stock, $0.001 par value5.75,250,000.0003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001214659-26-006201 Dispute this row
Ting Jia Common Stock, $0.001 par value5.75,250,000.0003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001214659-26-006201 Dispute this row
Blue Owl Capital Holdings LP Common Stock, par value $0.001 per share5.545,089,01503/31/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 2Open filing 0001140361-26-021316 Dispute this row
Avidity Partners Management LP Common Stock, par value $0.001 per share8.78,302,808.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Avidity Partners Management (GP) LLC Common Stock, par value $0.001 per share8.78,302,808.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Avidity Capital Partners Fund (GP) LP Common Stock, par value $0.001 per share8.78,302,808.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Avidity Capital Partners (GP) LLC Common Stock, par value $0.001 per share8.78,302,808.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Avidity Private Master Fund I LP Common Stock, par value $0.001 per share7.77,364,795.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Michael Gregory Common Stock, par value $0.001 per share8.78,302,808.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 5Open filing 0000919574-26-002869 Dispute this row
Soleus Capital Master Fund, L.P. Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Soleus Capital, LLC Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Soleus Capital Group, LLC Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Soleus Capital Management, L.P. Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Soleus GP, LLC Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Guy Levy Common Stock, par value $0.001 per share7.66,963,141.0003/31/2026 Filed 2026-05-08SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-053988 Dispute this row
Soleus Capital Master Fund, L.P. Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
Soleus Capital, LLC Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
Soleus Capital Group, LLC Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
Soleus Capital Management, L.P. Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
Soleus GP, LLC Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
Guy Levy Common Stock, par value $0.001 per share5.24,776,398.0002/02/2026 Filed 2026-02-03SCHEDULE 13GOpen filing 0001213900-26-011516 Dispute this row
MPM BioImpact LLC Common Stock, par value $0.001 per share11.610,679,391.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001687078-26-000005 Dispute this row
Great Point Partners, LLC Common Stock5.104,683,711.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 6Open filing 0001172661-26-001118 Dispute this row
Dr. Jeffrey R. Jay, M.D. Common Stock5.104,683,711.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 6Open filing 0001172661-26-001118 Dispute this row
Ms. Lillian Nordahl Common Stock5.104,683,711.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 6Open filing 0001172661-26-001118 Dispute this row
Great Point Partners, LLC Common Stock5.224,683,711.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 5Open filing 0001814554-25-000171 Dispute this row
Dr. Jeffrey R. Jay, M.D. Common Stock5.224,683,711.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 5Open filing 0001814554-25-000171 Dispute this row
Ms. Lillian Nordahl Common Stock5.224,683,711.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 5Open filing 0001814554-25-000171 Dispute this row
Avidity Partners Management LP Common Stock, par value $0.001 per share9.99,200,580.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Partners Management (GP) LLC Common Stock, par value $0.001 per share9.99,200,580.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Capital Partners Fund (GP) LP Common Stock, par value $0.001 per share9.99,200,580.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Capital Partners (GP) LLC Common Stock, par value $0.001 per share9.99,200,580.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Master Fund LP Common Stock, par value $0.001 per share4.94,510,100.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Private Master Fund I LP Common Stock, par value $0.001 per share8.27,776,296.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Avidity Private Master Fund I LP Common Stock, par value $0.001 per share8.27,776,296.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Michael Gregory Common Stock, par value $0.001 per share9.99,200,580.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-007016 Dispute this row
Great Point Partners, LLC Common Stock5.224,683,711.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003532 Dispute this row
Dr. Jeffrey R. Jay, M.D. Common Stock5.224,683,711.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003532 Dispute this row
Ms. Lillian Nordahl Common Stock5.224,683,711.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003532 Dispute this row
Avidity Partners Management LP Common Stock, par value $0.001 per share9.99,126,176.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0000919574-25-004877 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,694,798 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015111,180
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Context Therapeutics Inc.